SandboxAQ’s AQMed Reflects on a Year of Scientific and Technical Achievements | PR Newswire [Video]

– Developed first-of-its-kind unshielded MCG device for bedside use, published in MDPI Sensors

– Presented AI applications in MCG at Frontiers of Cardiovascular Medicine special issue

– Breakthrough clinical results on N-STEMI diagnostics presented at AHA Scientific Sessions

– Launched Mayo Clinic partnership for angiography correlation study involving 150 patients

, /PRNewswire/ — SandboxAQ is proud to announce a year of exceptional progress and innovation from its AQMed division. Combining artificial intelligence with advanced sensors, AQMed empowers clinicians to make faster and more accurate heart health decisions. This transformative work has been featured in the McKinsey report Quantum Sensing’s Untapped Potential: Insights for Leaders and highlighted by AQMed GM Dr. Kit Yee Au-Yeung during The Economist‘s Commercialising Quantum Global 2024 and in the World Economic Forum’s Quantum for Society: Meeting the Ambition of the Sustainable Development Goals. Today, AQMed reflects on its technical milestones that are paving the way for improved patient care.

Point-of-Care Diagnostics with Innovative Magnetocardiography Hardware

At the Conference on Lasers …